An orthopedic surgery department is preparing to transition to a new manufacturer for custom total joint arthroplasty implants. The new implants arrive in packaging that is significantly different from the previous vendor's supplies. Although no adverse events have occurred at this facility, the chief medical officer is concerned about the potential for laterality errors (e.g., confusing right-sided and left-sided implants) during the sterile preparation phase. Before scheduling the first case with the new hardware, the quality improvement team convenes to evaluate the upcoming workflow. They diagram the steps of the implant verification process, assign numerical values to the likelihood of a packaging mix-up, the severity of patient harm if a mix-up occurs, and the probability of detecting the error before the surgical incision. They then implement a mandatory barcode-scanning step to address the vulnerabilities with the highest calculated scores. Which of the following methodologies did this team most likely utilize?
- Failure mode and effects analysisCevap
- BRoot cause analysis
- CPlan-Do-Study-Act cycle
- DSentinel event review
- EIshikawa (fishbone) diagramming